APA

Dalle S., Poulalhon N., Debarbieux S., Zaharia D., Mihm M. C., Lacouture M. E., Rosen A., Marghoob A. A., Busam K. J., Depaepe L., Bringuier P., Richez P., Baurain J., Bressac-de Paillerets B., Balme B. & Thomas L. (20130730). Tracking of second primary melanomas in vemurafenib-treated patients. : JAMA dermatology.

Chicago

Dalle Stephane, Poulalhon Nicolas, Debarbieux Sébastien, Zaharia Daniela, Mihm Martin C, Lacouture Mario E, Rosen Alyx, Marghoob Ashfaq A, Busam Klaus J, Depaepe Lauriane, Bringuier Pierre-Paul, Richez Pauline, Baurain Jean-François, Bressac-de Paillerets Brigitte, Balme Brigitte and Thomas Luc. 20130730. Tracking of second primary melanomas in vemurafenib-treated patients. : JAMA dermatology.

Harvard

Dalle S., Poulalhon N., Debarbieux S., Zaharia D., Mihm M. C., Lacouture M. E., Rosen A., Marghoob A. A., Busam K. J., Depaepe L., Bringuier P., Richez P., Baurain J., Bressac-de Paillerets B., Balme B. and Thomas L. (20130730). Tracking of second primary melanomas in vemurafenib-treated patients. : JAMA dermatology.

MLA

Dalle Stephane, Poulalhon Nicolas, Debarbieux Sébastien, Zaharia Daniela, Mihm Martin C, Lacouture Mario E, Rosen Alyx, Marghoob Ashfaq A, Busam Klaus J, Depaepe Lauriane, Bringuier Pierre-Paul, Richez Pauline, Baurain Jean-François, Bressac-de Paillerets Brigitte, Balme Brigitte and Thomas Luc. Tracking of second primary melanomas in vemurafenib-treated patients. : JAMA dermatology. 20130730.